stellantis
- Fri, 16 Jan 2026
Stellantis CEO: 2026 is the ‘year of execution’ as Wall Street awaits turnaround strategy
biotech
- Fri, 16 Jan 2026
Making U.S. biotech more competitive with China's could help rare disease patients, experts say
Newsletter
Subscribe to our mailing list to get the new updates!
Subscribe our newsletter to stay updated